Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 System Security: Difference between revisions

From GxPlex

Jump to: navigation, search
gxplex>GxPlexBot
Import from GxPlex Excel
Migrate to Template:ReferenceData for PageForms (GxPlexBot)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447
|has_document=Document:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447
|RefScope=G
|module=4
|RefDocPart=System Security
|unit=4.3.4
|RefLanguage=EN
|scope=G
|RefTags=TAG-00127-Com-meC ++ TAG-00294-Rem-gFe ++ TAG-00063-Dat-per ++ TAG-00017-Spo-die ++ TAG-00137-Mon-che
|doc_part=System Security
|RefModule=4
|language=EN
|RefUnit=4.3.4
|entry_by=Florian Adragna
}}
|contributors=
Β 
|tags=TAG-00127-Com-meC ++ TAG-00294-Rem-gFe ++ TAG-00063-Dat-per ++ TAG-00017-Spo-die ++ TAG-00137-Mon-che
{{:Document:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447}}
|tags_display=[[Glossary:TAG-00127-Com-meC|Systems validation]], [[Glossary:TAG-00294-Rem-gFe|Remote access]], [[Glossary:TAG-00063-Dat-per|Data protection]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00137-Mon-che|Monitoring]]
Β 
|comment=System security for remote access monitoring
{| class="wikitable gplx-infobox"
|content=System Security
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 4 β€” Unit 4.3.4
|-
! Scope
| G
|-
! Document part
| System Security
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00127-Com-meC|Systems validation]], [[Glossary:TAG-00294-Rem-gFe|Remote access]], [[Glossary:TAG-00063-Dat-per|Data protection]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00137-Mon-che|Monitoring]]
|-
! Comment
| System security for remote access monitoring
|}
Β 
== Content ==
System Security
[...]
[...]
There should be the implementation of robust security procedures by the sponsor and investigator site/institution, such as; password criteria and renewal rules, firewalls, virus and malware protection, penetration testing (to identify vulnerabilities), system monitoring for detection of inappropriate/unusual activities/intrusions and changes to network configurations, threat intelligence software, physical security considerations at data centres and timely implementation of any security updates/patches.
There should be the implementation of robust security procedures by the sponsor and investigator site/institution, such as; password criteria and renewal rules, firewalls, virus and malware protection, penetration testing (to identify vulnerabilities), system monitoring for detection of inappropriate/unusual activities/intrusions and changes to network configurations, threat intelligence software, physical security considerations at data centres and timely implementation of any security updates/patches.
Line 51: Line 21:
[...]
[...]
6. The model clinical trial agreements require that Monitors (or Auditor) are suitably trained to understand information governance requirements. There should be training courses put in place by the sponsor to cover the protection of trial participants’ data confidentiality in relation to the contractual obligations of the sponsor with the investigator site/institutions. [...]
6. The model clinical trial agreements require that Monitors (or Auditor) are suitably trained to understand information governance requirements. There should be training courses put in place by the sponsor to cover the protection of trial participants’ data confidentiality in relation to the contractual obligations of the sponsor with the investigator site/institutions. [...]
}}

Revision as of 12:56, 16 July 2026



Document information
Reference GBR Guidance

Access to Electronic Health Records by Sponsor representatives in clinical trials 44447

Validity area GBR
Scope(s) G
Document name Guidance

Access to Electronic Health Records by Sponsor representatives in clinical trials

Version / Revision 2021-09-08 00:00:00
Status Current
Document type Official recommendation
Language(s) EN
Description Guidance

Access to Electronic Health Records by Sponsor representatives in clinical trials The following guidance has been jointly developed by the Heath Research Authority (HRA) and MHRA, in consultation with the Information Commissioners Office (ICO), on behalf of the UK.

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 4 β€” Unit 4.3.4
Scope G
Document part System Security
Language EN
Original entry by Florian Adragna
Contributors
Tags Systems validation, Remote access, Data protection, Sponsor, Monitoring

Content

System Security [...] There should be the implementation of robust security procedures by the sponsor and investigator site/institution, such as; password criteria and renewal rules, firewalls, virus and malware protection, penetration testing (to identify vulnerabilities), system monitoring for detection of inappropriate/unusual activities/intrusions and changes to network configurations, threat intelligence software, physical security considerations at data centres and timely implementation of any security updates/patches. [...] Controls Implemented by the Sponsor (or authorised delegated party, e.g. CRO) [...] 3. Remote Log-in Access to the EHR system at UK sites must only be undertaken from a physical location in the UK, an EEA state, or another state covered by a UK adequacy decision 4. The device through which remote Log-in Access to the EHR system is used should be provided by the sponsor, or the sponsor should have undertaken an assessment of the security processes applied to the device(s) [...]5. The sponsor must not record any video calls where screen sharing of guided direct access or of paper source documentation has taken place. There must be no records of any trial participant information in any β€œchat” function of the remote video call. [...] 6. The model clinical trial agreements require that Monitors (or Auditor) are suitably trained to understand information governance requirements. There should be training courses put in place by the sponsor to cover the protection of trial participants’ data confidentiality in relation to the contractual obligations of the sponsor with the investigator site/institutions. [...]